SOAT1 and rheumatoid arthritis: TT0 and T6M from the TETRAD study provided a unique opportunity to explore whether the attenuated cytokine-induced Jak/STAT signaling seen in RA can be altered in immune cells after initiation of a DMARD or biologic drug.